Skip to main content
. Author manuscript; available in PMC: 2012 Aug 21.
Published in final edited form as: Drug Dev Res. 1998 Dec 21;45(2):52–66. doi: 10.1002/(SICI)1098-2299(199810)45:2<52::AID-DDR2>3.0.CO;2-V

TABLE 1.

MS and HPLC Characterization of PPADS Analogues Synthesizeda

FAB (M-H+)
HPLC (rate, min)
Compoundb Formula Calculated Found System A System B
2 C14H13O6N3PNa2 396.0337 396.0345 10.15 13.64
4 C14H13O9N3PSNa 451.9929 451.9935 8.84 14.01
8 C15H15O10N3PSNa 482.0035 482.0015 8.80 14.33
9 C15H13O8N3P 394.0440 394.0407 9.14 14.06
10 C15H13O8N3PNa 416.0260 416.0251 7.90 13.94
11 C15H12ON3ClPNa 449.9870 449.9869 8.56 14.18
12 C14H13O6N3ClP 384.0152 384.0155 11.93 14.93
13 C14H12O9N3ClPSNa 485.9540 485.9560 9.40 15.21
14 C15H12O8N3ClPNa 428.0050 428.0049 10.09 15.33
15 C15H12O8N3ClPNa 450.9948 450.9965 7.94 14.07
16 C14H12O8N4ClP 429.0003 428.9997 12.07 15.11
19 C8H10O5NP 230.0218 230.0217 7.63 8.70
20 Cl4Hl1Ol1N3PS2Na3 559.9187 559.9183 8.22 15.22
21 C14H12O8N3ClPSNa 469.9591 469.9583 10.80 14.64
22 C9H12O5NP 244.0375 244.0380 7.54 9.76
23 C15H15O11N3PS2Na3 575.9500 575.9501 8.13 15.62
24 C15H14O8ClPSNa 483.9747 483.9756 10.32 15.00
25 C16H15O7N3P 392.0648 392.0645 8.49 12.41
26 C9H10O5NP 242.0218 242.0220 8.11 9.36
27 C15H12O11N3PS2Na3 571.9187 571.9256 7.13 13.58
28 C10H14O5NP 258.0531 258.0544 8.72 9.39
29 C16H17O11N3PS2Na 543.9862 543.9827 9.19 15.38
30 C16H16O8N3ClPSNa 497.9904 497.9890 11.20 15.18
31 C10H12O5NP 256.0371 256.0375 9.25 10.05
32 C18H14O12N3PS2Na2 581.9654 581.9670 8.37 15.82
33 C18H14O12N3PS2Na2 581.9654 581.9647 8.29 15.78
34 C18H14O15N3PS2Na2 683.9042 683.9044 7.50 16.74
a

MS, mass spectrum; HPLC, high pressure liquid chromatography; PPADS, pyridoxal-6′-phosphate-b-phenylazo-2,4-disulfonate; FAB, fast atom bombardment. System A was 0.1 M triethylammonium acetate buffer:CH3CN = 95:5 to 40:60 for 20 min wtih flow rate 1 ml/min. System B was 5 mM tetrabutylammonium phosphate buffer:CH3CN 80:20 to 40:60, in 20 min with flow rate 1 ml/min.

b

Structures are shown in Table 2 and Schemes 1 and 2.